Chronic constipation responds to treatment, but the approach that works depends on why it is happening. For roughly a third of people, simple changes to diet and physical activity are enough. For others, over-the-counter osmotic laxatives like polyethylene glycol have strong evidence behind them. And for a sizable group whose muscles are not coordinating properly during bowel movements, the most effective treatment is not a medication at all but a form of physical retraining called biofeedback. The challenge is that many people cycle through remedies for years without anyone figuring out which subtype of constipation they have, and that distinction changes what will actually help.
Fiber, Fruit, and Physical Activity
The first-line advice you will hear from any gastroenterologist is to increase dietary fiber. That advice is not wrong, but the specifics matter more than the slogan. A head-to-head trial comparing green kiwifruit, psyllium husk, and prunes in people with chronic constipation found that all three increased the number of complete spontaneous bowel movements per week. Kiwifruit and prunes both improved stool consistency, and all three reduced straining.1PubMed. Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation This study is worth knowing about because it suggests you do not need to force yourself to eat a specific “superfood.” Psyllium, kiwifruit, and prunes are roughly comparable, so pick whichever one you will actually stick with. The key is getting soluble fiber consistently, not sporadically.
Physical activity also has good evidence behind it. A systematic review of cohort studies found that aerobic exercise and core-strengthening exercise can reduce the time it takes material to move through your colon.2PubMed Central. Physical activity and constipation: A systematic review of cohort studies That said, there is a sweet spot. Light to moderate exercise lasting under about an hour seems to be the most helpful. Prolonged or very intense exercise may actually slow gut motility and make symptoms worse, and the benefits of exercise depend partly on whether hydration and fiber intake are adequate.3Quality in Sport. Clinical management of constipation – the role of physical activity – systematic review So the advice to “just exercise more” is broadly right, but doing a three-hour endurance workout while dehydrated is not the path forward.
Osmotic Laxatives Are the Workhorse
When lifestyle changes alone are not enough, polyethylene glycol (sold under brand names like MiraLAX and Movicol) is the most widely studied and recommended over-the-counter option. It works by drawing water into the colon, softening stool and making it easier to pass. A six-month placebo-controlled study found that about three-quarters of patients on PEG were free of constipation symptoms by the end, compared with roughly one in five on placebo. Bowel frequency nearly doubled, and patients needed fewer rescue laxatives over time.4PubMed Central. Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation
Safety data on PEG is reassuring even for long-term use. A year-long open-label study covering over 200 patient-years found that the main side effects were mild gastrointestinal complaints like loose stools and gas, and there were no meaningful changes in blood chemistry or electrolytes, including in elderly patients.5PubMed. An open-label study of chronic polyethylene glycol laxative use in chronic constipation This matters because one of the most common fears people have is that daily laxative use will somehow damage their gut or create dependency. For PEG, the evidence does not support that worry.
Stimulant Laxatives Are Safer Than Their Reputation
Bisacodyl and sodium picosulfate are the most common stimulant laxatives, and they have been dogged for decades by the belief that using them regularly will make your colon “lazy” or cause nerve damage. A critical review of the evidence found no good support for that claim. There is no evidence that stimulant laxatives at recommended doses cause structural damage to the nerves or smooth muscle of the gut.6PubMed Central. Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge The old idea of “cathartic colon” came from case reports involving now-discontinued products and extremely high doses, not from modern stimulant laxatives at normal use.
In clinical trials, bisacodyl and sodium picosulfate produced positive outcomes in roughly 80 to 99 percent of patients by global assessment, significantly more than placebo. The trade-off is that side effects like diarrhea and abdominal cramping are common, reported in up to about 70 percent of users, though they tend to be mild.7PubMed. Long term treatment with stimulant laxatives – clinical evidence for effectiveness and safety? So stimulant laxatives are not the first thing to reach for, but there is no reason to fear them if osmotic laxatives alone are not enough. The bigger problem is that many people self-treat with stimulants for years when they actually have a subtype of constipation that responds much better to a completely different approach.
Why Your Subtype Matters More Than Your Laxative
Chronic constipation is not one condition. The Rome IV classification system breaks it into several subtypes: functional constipation, constipation-predominant irritable bowel syndrome, opioid-induced constipation, and functional defecation disorders including dyssynergic defecation.8Taylor & Francis Online / Expert Review of Gastroenterology & Hepatology. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation These categories matter because the treatment that works best is different for each one.
Consider dyssynergic defecation, where the muscles of the pelvic floor and anal sphincter do not relax properly (or even paradoxically tighten) when you try to have a bowel movement. This is essentially a coordination problem, not a motility problem. In one study of 230 patients referred for chronic constipation, about a fifth had dyssynergic defecation, while roughly 40 percent had slow transit constipation, and 13 percent had both.9PubMed Central. Prevalence and Clinical Characteristics of Dyssynergic Defecation and Slow Transit Constipation in Patients with Chronic Constipation The overlap is important: about 60 percent of those with dyssynergic defecation also had slow transit, meaning they might need treatment for both problems.
Diagnosing dyssynergia is not as straightforward as it sounds. The standard test, anorectal manometry, measures pressures in the rectum and anal canal during attempted defecation. Normally, rectal pressure rises while the external anal sphincter relaxes. In dyssynergia, that coordination breaks down in one of several ways: inadequate pushing force, a paradoxical squeeze of the sphincter, impaired relaxation, or some combination.10Journal of Neurogastroenterology and Motility. Diagnosis and Treatment of Dyssynergic Defecation However, the test has a notable limitation. A study comparing patients with functional constipation to healthy volunteers found that dyssynergic patterns on manometry were almost as common in healthy people as in constipated patients, showing up in 87 percent of healthy volunteers versus 94 percent of constipated patients.11PubMed Central. Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defaecation That means manometry alone can overdiagnose the condition. Clinicians generally need to combine it with other tests and clinical history to be confident.
Biofeedback for Dyssynergic Defecation
If dyssynergia is confirmed, the most effective treatment is biofeedback therapy, not laxatives. Biofeedback uses sensors and visual or auditory feedback to teach you how to coordinate your pelvic floor muscles correctly during defecation. In a landmark randomized trial, 80 percent of patients who completed five biofeedback sessions reported major improvement at six months, compared with 22 percent of those treated with PEG laxative alone. The benefits held up at one and two years of follow-up.12Gastroenterology. Biofeedback Is Superior to Laxatives for Normal Transit Constipation Due to Pelvic Floor Dyssynergia
Across multiple randomized controlled trials, biofeedback has proven more effective than laxatives, muscle relaxant drugs, and sham biofeedback (general relaxation exercises) for dyssynergic defecation. Its effectiveness is specific to that subtype: it does not help people whose problem is slow transit constipation without a defecation coordination issue.13PubMed Central. Biofeedback therapy for dyssynergic defecation This specificity underscores why getting the right diagnosis matters. If your constipation is caused by a coordination problem, no amount of fiber or PEG will fully resolve it. You need to retrain the muscles.
The main drawback of biofeedback is access. It requires skilled staff and specialized equipment, and is only available at certain centers. Research into home-based biofeedback devices is underway, though the evidence comparing home-based to office-based approaches is still developing.14The Lancet Gastroenterology & Hepatology. Home-based versus office-based biofeedback therapy for constipation and dyssynergic defecation: a randomised controlled trial
Prescription Medications When Over-the-Counter Options Fall Short
Several prescription drugs are available for chronic constipation that does not respond to fiber, lifestyle changes, and over-the-counter laxatives. They work through different mechanisms, and their side-effect profiles are distinct enough to matter when choosing between them.
Lubiprostone increases chloride secretion into the intestinal lumen, which pulls water and sodium in passively, speeding up transit. Randomized trials have shown it to be effective for chronic constipation, constipation-predominant IBS, and opioid-induced constipation.15PubMed Central. Lubiprostone in constipation: clinical evidence and place in therapy Its most notable side effect is nausea, which leads some patients to stop taking it.
Linaclotide works on a different receptor in the gut lining, stimulating fluid secretion and accelerating transit. It is approved at one dose for chronic constipation and a higher dose for constipation-predominant IBS.16PubMed Central. Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation Its characteristic side effect is diarrhea rather than nausea. A meta-analysis comparing lubiprostone, linaclotide, and the bile acid transporter inhibitor elobixibat found similar overall effectiveness among the three, but lubiprostone was most associated with nausea, linaclotide with diarrhea, and elobixibat with abdominal pain.17PubMed Central. Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm This means there is room to switch between agents if one causes intolerable side effects.
Prucalopride takes a different approach entirely: it is a highly selective serotonin receptor agonist that stimulates gut motility. Multiple large randomized trials have shown it to be effective across a range of ages, ethnicities, and both sexes, without the cardiac side effects that plagued older serotonin-based drugs.18PubMed Central. An update on prucalopride in the treatment of chronic constipation In patients with slow transit, prucalopride at the standard dose cut colonic transit time by roughly 12 hours compared to placebo. For those with very slow transit at baseline, the improvement was even larger, and more than a third achieved a normal transit time.19PubMed Central. Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
Opioid-Induced Constipation Is Its Own Problem
If your constipation is caused by opioid pain medications, standard laxatives often fall short because the mechanism is different. Opioids act on receptors throughout the gut, slowing motility, reducing fluid secretion, and increasing absorption of water from stool, all of which combine to create a stubborn form of constipation.20PubMed Central. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
A class of drugs called peripherally acting mu-opioid receptor antagonists (PAMORAs) was designed specifically for this situation. They block opioid effects in the gut without crossing into the brain, so they relieve constipation without reducing pain relief. A meta-analysis of 20 randomized trials involving over 5,600 patients found that PAMORAs significantly improved spontaneous bowel movements from baseline and nearly doubled the likelihood of a treatment response compared to placebo. Quality of life also improved.21PubMed. Peripherally acting μ-opioid antagonist for the treatment of opioid-induced constipation: Systematic review and meta-analysis If you are on chronic opioid therapy and dealing with constipation, asking about a PAMORA (names like naloxegol, methylnaltrexone, or naldemedine) is worth a conversation with your prescriber.
The Squatting Angle and Defecation Posture
A surprisingly simple mechanical factor gets overlooked in many conversations about constipation: the angle at which you sit. When sitting on a standard toilet, the anorectal angle is partially kinked. Squatting straightens that angle, reducing the effort needed to evacuate. A study of healthy volunteers using a defecation posture modification device (essentially a footstool that raises your knees above your hips) found that it emulated characteristics of squatting, increased the sensation of complete emptying, and reduced the time spent on the toilet.22PubMed Central. Implementation of a Defecation Posture Modification Device Impact on Bowel Movement Patterns in Healthy Subjects This is not a cure for chronic constipation by itself, but for people who strain and feel like they cannot fully empty, a cheap footstool in front of the toilet can make a measurable difference alongside other treatments.
Treating Constipation in Children
Childhood constipation is extremely common and tends to follow a slightly different treatment path. The standard approach starts with education and demystification (many children develop withholding behavior out of fear or past painful experiences), toilet training with a reward system, and a defecation diary. Pharmacologically, PEG is the first-line choice, just as it is in adults.23PubMed Central. Management of Functional Constipation in Children: Therapy in Practice
A key difference in children is that fecal impaction is more common as a presenting problem, and treatment often begins with a disimpaction phase before moving to maintenance. Studies have found that high-dose PEG with electrolytes can clear impaction in three to four days, with children beginning to pass stool within 10 to 12 hours.24PubMed. Disimpaction of children with severe constipation in 3-4 days in a suburban clinic using polyethylene glycol with electrolytes and sodium picosulphate This can be done at home rather than in a hospital, and a randomized trial found home-based disimpaction to be just as effective, with fewer side effects and lower cost.25PubMed. Efficacy of Home-Based Versus Hospital-Based Disimpaction with Polyethylene Glycol in Pediatric Functional Constipation: A Randomized Control Study PEG safety data in children is also reassuring: a study evaluating an average of nearly nine months of daily PEG use found no major clinical side effects and normal blood work, and every child in the study preferred PEG to their previous laxatives.26JAMA Pediatrics. Safety of Polyethylene Glycol 3350 for the Treatment of Chronic Constipation in Children
One important note: unlike in adults, biofeedback for dyssynergic defecation in children has not shown clear superiority over laxative therapy in controlled trials. The behavioral and developmental dimensions of childhood constipation are different enough that the adult treatment hierarchy does not transfer cleanly.
Older Adults Face Compounding Factors
Constipation becomes more common with age, but it is not an inevitable part of aging so much as a consequence of things that accumulate with age. Reduced physical activity, multiple medications (many of which slow the gut as a side effect), chronic medical conditions, and changes in rectal sensitivity all contribute.27PubMed Central. Chronic Constipation in the Elderly Patient: Updates in Evaluation and Management The recommended approach in older adults is individualized but typically starts with a medication review (calcium channel blockers, anticholinergics, and iron supplements are frequent culprits), lifestyle adjustments, and then the same laxative stepladder used in younger adults. The safety data for PEG in elderly populations is consistent with the general adult data: no significant electrolyte shifts or other laboratory concerns over a year of use.
Surgery as a Last Resort
For the small number of people with severe slow-transit constipation who have exhausted medical options, surgery is considered. The candidates are carefully selected: typically at least five years of documented severe constipation, fewer than two bowel movements per week despite aggressive medical therapy, no evidence of pelvic floor dysfunction or small-bowel motility problems, and a strong personal desire to proceed. The two main surgical options are subtotal colectomy with ileorectal anastomosis and subtotal colectomy with caecorectal anastomosis.28PubMed Central. Surgical outcomes of subtotal colectomy with antiperistaltic caecorectal anastomosis vs total colectomy with ileorectal anastomosis for intractable slow-transit constipation Both procedures substantially increase bowel frequency, typically to about three movements per day, and quality-of-life scores improve significantly. Complication rates are substantial (around a quarter to a third of patients experience post-operative complications), but for people whose lives have been dominated by refractory constipation for years, the outcomes tend to be worth it.
The Placebo Effect Is Unusually Strong in Constipation Trials
One underappreciated aspect of constipation research is how much people improve on placebo. A meta-analysis of 46 clinical trials involving nearly 6,000 placebo-arm patients found that about 29 percent of people given a sugar pill reported improvement. When improvement was measured by subjective self-report rather than objective bowel-movement counts, the placebo response rate climbed to over 40 percent.29PubMed Central. Impact of Clinical Outcome Measures on Placebo Response Rates in Clinical Trials for Chronic Constipation: A Systematic Review and Meta-analysis
This does not mean constipation treatments are ineffective. It means that the experience of being enrolled in a trial, paying more attention to diet and habits, and expecting improvement can move the needle substantially on its own. It also means that some of the benefit people attribute to supplements, teas, or other unproven remedies may be placebo response rather than a pharmacological effect. The drugs that demonstrate clear separation from placebo in well-controlled trials (PEG, linaclotide, prucalopride, PAMORAs, biofeedback) are genuinely doing something beyond expectation effects. That is a useful filter when evaluating the flood of constipation products marketed online.
The Gut Microbiome and Emerging Approaches
Research into the gut microbiome’s role in constipation is active but still early. People with chronic constipation tend to have different microbial profiles than those without, and the metabolic products of gut bacteria, particularly short-chain fatty acids and serotonin precursors, are involved in regulating motility. Probiotics modestly improve symptoms in some trials, and the working theory is that certain microbial shifts can influence gut movement through effects on the enteric nervous system, immune signaling, and intestinal secretion.30PubMed Central. Crosstalk between the Gut Microbiome and Colonic Motility in Chronic Constipation: Potential Mechanisms and Microbiota Modulation The evidence is not yet strong enough to recommend specific probiotic strains with confidence for constipation, but this is one of the more promising research directions. Gut-focused hypnotherapy, which uses guided imagery to help patients modulate gut function, has also shown promise for functional gastrointestinal disorders broadly, though most of the robust data so far is in irritable bowel syndrome rather than constipation specifically.31PubMed Central. Gut‐focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence‐base, practical aspects, and the Manchester Protocol